Astrocyte loss and astrogliosis in neuroinflammatory disorders
- 1 April 2014
- journal article
- review article
- Published by Elsevier in Neuroscience Letters
- Vol. 565, 39-41
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- Cerebral hypoperfusion in multiple sclerosis is reversible and mediated by endothelin-1Proceedings of the National Academy of Sciences, 2013
- Age exaggerates proinflammatory cytokine signaling and truncates signal transducers and activators of transcription 3 signaling following ischemic stroke in the ratNeuroscience, 2010
- Endothelin-1 Regulates Astrocyte Proliferation and Reactive Gliosis via a JNK/c-Jun Signaling PathwayJournal of Neuroscience, 2008
- Astrocytes are a specific immunological target in Rasmussen's encephalitisAnnals of Neurology, 2007
- Pathogenesis, diagnosis and treatment of Rasmussen encephalitis: A European consensus statementBrain, 2005
- Pathophysiology of Cerebral Ischemia and Brain Trauma: Similarities and DifferencesJournal of Cerebral Blood Flow & Metabolism, 2004
- Astrocytes in multiple sclerosis lack beta-2 adrenergic receptorsNeurology, 1999
- Attenuation of Astroglial Reactivity by Interleukin-10Journal of Neuroscience, 1996
- Reactive astrogliosis in the neonatal mouse brain and its modulation by cytokinesJournal of Neuroscience, 1994
- IκB: a Specific Inhibitor of the NF-κB Transcription FactorScience, 1988